Regulation & law · 02/09/2015
National Institutes of Health to Consider Exclusive Patent License for Biomarkers for Acute Ischemic Stroke
The National Institutes of Health is seeking to grant a co-exclusive patent license to CereDx, Inc. for the use of biomarkers for acute ischemic stroke, as outlined in a U.S. patent application filed in 2012.
Original source language: Federal Register — All DocumentsOpen original release →